{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:06:14Z","timestamp":1789754774933,"version":"4.0.1"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R35-CA283706"],"award-info":[{"award-number":["R35-CA283706"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Microbiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.tim.2026.08.013","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:14:51Z","timestamp":1789071291000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular pathways linking the gut microbiome to antitumor immunity"],"prefix":"10.1016","author":[{"given":"Ximena","family":"Diaz-Olea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda E.","family":"Ramer-Tait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Osterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3859-0400","authenticated-orcid":false,"given":"Zeev A.","family":"Ronai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tim.2026.08.013_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2024.102819","article-title":"Bacteroides and related species: the keystone taxa of the human gut microbiota","volume":"85","author":"Shin","year":"2024","journal-title":"Anaerobe"},{"key":"10.1016\/j.tim.2026.08.013_bb0010","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41568-023-00594-2","article-title":"Bacteria in cancer initiation, promotion and progression","volume":"23","author":"El Tekle","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tim.2026.08.013_bb0015","doi-asserted-by":"crossref","first-page":"9474","DOI":"10.3390\/ijms22179474","article-title":"Chemotherapy-induced intestinal microbiota dysbiosis impairs mucosal homeostasis by modulating toll-like receptor signaling pathways","volume":"22","author":"Wei","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tim.2026.08.013_bb0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41698-025-01034-0","article-title":"The role of the gut microbiota in chemotherapy response, efficacy and toxicity: a systematic review","volume":"9","author":"Bohm","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.tim.2026.08.013_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.586392","article-title":"The impact of gut microbiota on radiation-induced enteritis","volume":"11","author":"Jian","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.tim.2026.08.013_bb0030","article-title":"Persistent dysbiosis of intestinal and oral microbiota after neoadjuvant radiotherapy for rectal cancer: implications for surgery and microbiome intervention","volume":"16","author":"Zhang","year":"2026","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tim.2026.08.013_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.71866","article-title":"Chronic antibiotic use, gut microbiota dysbiosis, and increased risk of colorectal cancer: an emerging threat","volume":"9","author":"Mohiuddin","year":"2026","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.tim.2026.08.013_bb0040","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.2024025366","article-title":"Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy","volume":"145","author":"Prasad","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.tim.2026.08.013_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100829","article-title":"Microbiota-driven mechanisms at different stages of cancer development","volume":"32","author":"Ivleva","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.tim.2026.08.013_bb0050","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.immuni.2017.04.008","article-title":"Homeostatic immunity and the microbiota","volume":"46","author":"Belkaid","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2026.08.013_bb0055","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.trecan.2025.04.007","article-title":"Epigenetic mechanisms in melanoma development and progression","volume":"11","author":"Joo","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.tim.2026.08.013_bb0060","article-title":"William Coley: the pioneer and the father of immunotherapy","volume":"16","author":"Munir","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.tim.2026.08.013_bb0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41522-025-00786-8","article-title":"Gut microbiota shapes cancer immunotherapy responses","volume":"11","author":"Lei","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.tim.2026.08.013_bb0070","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.tim.2026.08.013_bb0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41522-023-00446-9","article-title":"Intracellular bacteria in cancer-prospects and debates","volume":"9","author":"Schorr","year":"2023","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.tim.2026.08.013_bb0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41698-024-00630-w","article-title":"Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy","volume":"8","author":"Elkrief","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.tim.2026.08.013_bb0085","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/cancers14051327","article-title":"Association between antibiotic exposure and systemic immune parameters in cancer patients receiving checkpoint inhibitor therapy","volume":"14","author":"von Itzstein","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tim.2026.08.013_bb0090","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jamaoncol.2019.2785","article-title":"Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer","volume":"5","author":"Pinato","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.tim.2026.08.013_bb0095","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdy103","article-title":"Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer","volume":"29","author":"Derosa","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tim.2026.08.013_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1075593","article-title":"A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint inhibitors","volume":"13","author":"Crespin","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tim.2026.08.013_bb0105","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.tim.2026.08.013_bb0110","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41586-025-08994-0","article-title":"Radiation-induced amphiregulin drives tumour metastasis","volume":"643","author":"Piffko","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tim.2026.08.013_bb0115","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/cancers16030472","article-title":"The aryl hydrocarbon receptor: impact on the tumor immune microenvironment and modulation as a potential therapy","volume":"16","author":"Griffith","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tim.2026.08.013_bb0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature06880","article-title":"Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor","volume":"453","author":"Quintana","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.tim.2026.08.013_bb0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature06881","article-title":"The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins","volume":"453","author":"Veldhoen","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.tim.2026.08.013_bb0130","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1074\/jbc.REV119.007759","article-title":"Cell adhesion in cancer: beyond the migration of single cells","volume":"295","author":"Janiszewska","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tim.2026.08.013_bb0135","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/carcin\/bgq028","article-title":"The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth","volume":"31","author":"Dietrich","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.tim.2026.08.013_bb0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12915-016-0240-y","article-title":"The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells","volume":"14","author":"Stanford","year":"2016","journal-title":"BMC Biol."},{"key":"10.1016\/j.tim.2026.08.013_bb0145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13046-020-01618-7","article-title":"3,3\u2019-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA\/ROCK1-mediated COX2\/PGE(2) pathway","volume":"39","author":"Zhu","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tim.2026.08.013_bb0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41392-025-02500-8","article-title":"The aryl hydrocarbon receptor: structure, signaling, physiology and pathology","volume":"11","author":"Coumoul","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tim.2026.08.013_bb0155","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","article-title":"Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity","volume":"55","author":"Hezaveh","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2026.08.013_bb0160","article-title":"Tryptophan metabolite indole-3-aldehyde induces AhR and c-MYC degradation to promote tumor immunogenicity","volume":"12","author":"Cui","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tim.2026.08.013_bb0165","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","article-title":"Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment","volume":"186","author":"Bender","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.tim.2026.08.013_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.111004","article-title":"The microbial metabolite I3A inhibits ferroptosis and the effectiveness of redox-based cancer therapy","volume":"302","author":"Guo","year":"2026","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tim.2026.08.013_bb0175","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/s44319-025-00386-9","article-title":"Modulating tumor immunity using advanced microbiome therapeutics producing an indole metabolite","volume":"26","author":"Vaaben","year":"2025","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tim.2026.08.013_bb0180","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41556-023-01314-6","article-title":"Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition","volume":"26","author":"Cui","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tim.2026.08.013_bb0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/toxins17010017","article-title":"The role of indoxyl sulfate in exacerbating colorectal cancer during chronic kidney disease progression: insights into the Akt\/beta-catenin\/c-Myc and AhR\/c-Myc pathways in HCT-116 colorectal cancer cells","volume":"17","author":"Ichisaka","year":"2025","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.tim.2026.08.013_bb0190","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2026.08.013_bb0195","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1038\/s41467-024-48397-9","article-title":"FLI1 promotes IFN-gamma-induced kynurenine production to impair anti-tumor immunity","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2026.08.013_bb0200","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41467-019-08887-7","article-title":"The aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2026.08.013_bb0205","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.7150\/ijbs.85712","article-title":"Akkermansia muciniphila inhibits tryptophan metabolism via the AhR\/beta-catenin signaling pathway to counter the progression of colorectal cancer","volume":"19","author":"Zhang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tim.2026.08.013_bb0210","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3390\/cancers12092411","article-title":"Indolepropionic acid, a metabolite of the microbiome, has cytostatic properties in breast cancer by activating AHR and PXR receptors and inducing oxidative stress","volume":"12","author":"Sari","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tim.2026.08.013_bb0215","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.3390\/cancers12102915","article-title":"Indoxylsulfate, a metabolite of the microbiome, has cytostatic effects in breast cancer via activation of AHR and PXR receptors and induction of oxidative stress","volume":"12","author":"Sari","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tim.2026.08.013_bb0220","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","article-title":"Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis","volume":"40","author":"Singh","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2026.08.013_bb0225","doi-asserted-by":"crossref","first-page":"E350","DOI":"10.1152\/ajpendo.00572.2018","article-title":"The pregnane X receptor and its microbiota-derived ligand indole 3-propionic acid regulate endothelium-dependent vasodilation","volume":"317","author":"Pulakazhi Venu","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tim.2026.08.013_bb0230","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.immuni.2014.06.014","article-title":"Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and toll-like receptor 4","volume":"41","author":"Venkatesh","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2026.08.013_bb0235","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1158\/0008-5472.CAN-08-4466","article-title":"GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon","volume":"69","author":"Thangaraju","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.tim.2026.08.013_bb0240","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fimmu.2018.00286","article-title":"The aryl hydrocarbon receptor and tumor immunity","volume":"9","author":"Xue","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2026.08.013_bb0245","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/2767-9764.CRC-25-0177","article-title":"Epigenetic modulation, intratumoral microbiome, and immunity in early-onset colorectal cancer","volume":"5","author":"Jin","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.tim.2026.08.013_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1449912","article-title":"Microbiota-metabolism-epigenetics-immunity axis in cancer","volume":"15","author":"Ren","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2026.08.013_bb0255","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.cell.2024.02.022","article-title":"Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer","volume":"187","author":"Jia","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.tim.2026.08.013_bb0260","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.cmet.2023.04.015","article-title":"Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8+ T cell immunity","volume":"35","author":"Zhang","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.tim.2026.08.013_bb0265","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2297846","article-title":"B. thetaiotaomicron-derived acetic acid modulate immune microenvironment and tumor growth in hepatocellular carcinoma","volume":"16","author":"Ma","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.tim.2026.08.013_bb0270","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","article-title":"Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer","volume":"12","author":"Luu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2026.08.013_bb0275","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.ccell.2024.08.019","article-title":"Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tim.2026.08.013_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116132","article-title":"Bifidobacterium animalis suppresses non-small cell lung cancer progression and modulates tumor immunity through indole-3-acetic acid","volume":"44","author":"Song","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.tim.2026.08.013_bb0285","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1158\/1078-0432.CCR-22-0784","article-title":"The crossroads of cancer epigenetics and immune checkpoint therapy","volume":"29","author":"Micevic","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tim.2026.08.013_bb0290","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bjh.13832","article-title":"Azacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup Study","volume":"172","author":"Prebet","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.tim.2026.08.013_bb0295","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/2159-8290.CD-11-0214","article-title":"Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer","volume":"1","author":"Juergens","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tim.2026.08.013_bb0300","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2249143","article-title":"Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell","volume":"15","author":"Zhu","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.tim.2026.08.013_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.556813","article-title":"Characterization of polysaccharide a response reveals interferon responsive gene signature and immunomodulatory marker expression","volume":"11","author":"Alvarez","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2026.08.013_bb0310","article-title":"Gut microbiota derived indole-3-acetic acid ameliorates precancerous inflammatory intestinal milieu to inhibit tumorigenesis through IL-35","volume":"13","author":"Wang","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.tim.2026.08.013_bb0315","article-title":"Gut colonization of Bacteroides plebeius suppresses colitis-associated colon cancer development","volume":"13","author":"Chen","year":"2025","journal-title":"Microbiol. Spectrum"},{"key":"10.1016\/j.tim.2026.08.013_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104834","article-title":"The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors","volume":"97","author":"Joachim","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tim.2026.08.013_bb0325","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1038\/s41467-025-65180-6","article-title":"The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regeneration","volume":"16","author":"Gottert","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2026.08.013_bb0330","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41591-022-01694-6","article-title":"Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial","volume":"28","author":"Dizman","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.tim.2026.08.013_bb0335","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.tim.2026.08.013_bb0340","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2147\/ITT.S485670","article-title":"JAK-STAT signaling in autoimmunity and cancer","volume":"14","author":"Parveen","year":"2025","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.tim.2026.08.013_bb0345","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41698-025-00960-3","article-title":"Bifidobacterium boosts anti-PD-1 effectiveness through JAK pathway in hepatocellular carcinoma","volume":"9","author":"Huo","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.tim.2026.08.013_bb0350","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12943-026-02588-8","article-title":"Tumour-infiltrating microplastics disrupt the JAK-STAT-microbiota axis to promote immunotherapy resistance in colorectal cancer","volume":"25","author":"Jiang","year":"2026","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tim.2026.08.013_bb0355","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2508949","article-title":"Indole-3-lactic acid suppresses colorectal cancer via metabolic reprogramming","volume":"17","author":"Zhou","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.tim.2026.08.013_bb0360","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00280-020-04059-3","article-title":"Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors","volume":"85","author":"Kawazoe","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tim.2026.08.013_bb0365","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.1206095","article-title":"The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota","volume":"332","author":"Round","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tim.2026.08.013_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116223","article-title":"Bifidobacteria-derived exopolysaccharide promotes anti-tumor immunity","volume":"44","author":"Silva de Oliveira","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.tim.2026.08.013_bb0375","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/s41467-019-09525-y","article-title":"Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5-\/- mice","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2026.08.013_bb0380","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mSphere.00587-18","article-title":"The protective role of Bacteroides fragilis in a murine model of colitis-associated colorectal cancer","volume":"3","author":"Lee","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.tim.2026.08.013_bb0385","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3389\/fmicb.2018.01588","article-title":"Toll-like receptor 2-mediated suppression of colorectal cancer pathogenesis by polysaccharide A from Bacteroides fragilis","volume":"9","author":"Sittipo","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tim.2026.08.013_bb0390","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tim.2026.08.013_bb0395","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3332\/ecancer.2019.905","article-title":"The use of intravesical BCG in urothelial carcinoma of the bladder","volume":"13","author":"Alhunaidi","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.tim.2026.08.013_bb0400","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2026.44.16_suppl.TPS8667","article-title":"Phase III study of multidisciplinary therapy combining local ablative therapy with immune-checkpoint inhibitors for patients with synchronous oligometastatic NSCLC (J-OLIGO: WJOG20924L)","volume":"44","author":"Miyawaki","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tim.2026.08.013_bb0405","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.16_suppl.TPS9604","article-title":"TeLuRide-006: an adaptive phase 2\/3 study of EIK1001, a toll-like receptor 7\/8 (TLR7\/8) agonist, in combination with pembrolizumab in patients with advanced melanoma","volume":"43","author":"Luke","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tim.2026.08.013_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1410928","article-title":"The role of the gut microbiota in tumor, immunity, and immunotherapy","volume":"15","author":"Xie","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tim.2026.08.013_bb0415","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1038\/s41467-023-41817-2","article-title":"Repressed Blautia-acetate immunological axis underlies breast cancer progression promoted by chronic stress","volume":"14","author":"Ye","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2026.08.013_bb0420","article-title":"Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growth","volume":"7","author":"Olea","year":"2026","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.tim.2026.08.013_bb0425","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.immuni.2024.02.014","article-title":"Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8+ T cell effector functions","volume":"57","author":"Cong","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.tim.2026.08.013_bb0430","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1038\/s41467-022-33116-z","article-title":"Inhibition of UBA6 by inosine augments tumour immunogenicity and responses","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2026.08.013_bb0435","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00262-025-04111-2","article-title":"Inosine shapes PD-1 blockade responses and synergizes with dual PD-1\/CTLA-4 immunotherapy to enhance antitumor immunity","volume":"74","author":"Narikawa","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.tim.2026.08.013_bb0440","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/s41467-020-16079-x","article-title":"Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer","volume":"11","author":"Coutzac","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2026.08.013_bb0445","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41467-025-67169-7","article-title":"Chemotherapy-driven intestinal dysbiosis and indole-3-propionic acid rewire myelopoiesis to promote a metastasis-refractory state","volume":"17","author":"Bersier","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2026.08.013_bb0450","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-59677-1","article-title":"Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody","volume":"14","author":"Murayama","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tim.2026.08.013_bb0455","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/2159-8290.CD-21-0808","article-title":"A natural polyphenol exerts antitumor activity and circumvents anti-PD-1 resistance through effects on the gut microbiota","volume":"12","author":"Messaoudene","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tim.2026.08.013_bb0460","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.4_suppl.TPS491","article-title":"Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC)","volume":"42","author":"Barragan-carrillo","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tim.2026.08.013_bb0465","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41590-025-02227-2","article-title":"The role of gut microbial metabolites in the T cell lifecycle","volume":"26","author":"Tran","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tim.2026.08.013_bb0470","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.3390\/ijms21207740","article-title":"Taming the sentinels: microbiome-derived metabolites and polarization of T cells","volume":"21","author":"Wojciech","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tim.2026.08.013_bb0475","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41419-023-05560-2","article-title":"Potential links between the microbiota and T cell immunity determine thetumor cell fate","volume":"14","author":"Mohseni","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tim.2026.08.013_bb0480","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.neo.2017.08.004","article-title":"Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients","volume":"19","author":"Frankel","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.tim.2026.08.013_bb0485","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-98973-2","article-title":"Integrating metagenomics and metabolomics to study the gut microbiome and host relationships in sports across different energy systems","volume":"15","author":"Aya","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tim.2026.08.013_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1528058","article-title":"Gut microbiota-derived metabolite phenylacetylglutamine inhibits the progression of prostate cancer by suppressing the Wnt\/beta-catenin signaling pathway","volume":"16","author":"Lv","year":"2025","journal-title":"Front. Pharmacol."}],"container-title":["Trends in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X26002453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X26002453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:23:46Z","timestamp":1789752226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X26002453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":98,"alternative-id":["S0966842X26002453"],"URL":"https:\/\/doi.org\/10.1016\/j.tim.2026.08.013","relation":{},"ISSN":["0966-842X"],"issn-type":[{"value":"0966-842X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular pathways linking the gut microbiome to antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Trends in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tim.2026.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}